Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-procedural antibiotics after cardiac device implantation
NCT03148444Phase 4Unknown
- Sponsor
- Kaplan Medical Center
- Start
- Jun 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of cefalexin, roxithromycin in bacterial infection, surgical site infection (SSI), sponsored by Kaplan Medical Center. Status: unknown.
02
Drugs
cefalexinroxithromycin
03
Conditions
bacterial infectionsurgical site infection (SSI)
Beyond the preview
Go deeper on NCT03148444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03148444.